Keywords: Abcam, Ascent Scientific, M&A, Biochemical reagents, Financial results fiscal 2010/11

Abcam to acquire biochemicals provider Ascent for $15.9 million; posts strong financials

Article | 14 September 2011

Print This

Protein research tools supplier Abcam (AIM: ABC) says it has entered into an agreement to acquire the entire issued share ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in